Recently, apolipoprotein A1 was shown to enhance the sensitivity of CA125 for detecting early stage epithelial ovarian cancer and suggested a promising therapeutic agent for the treatment of ovarian cancer [23], [38]. This evidence concerns the gene APOA1 and ovarian cancer.